Example: Heart Attack

Clinical Trials on Fibroma

Total 113 results

    • NCT02610985
      Unknown status
      2-D and 3-D Laparoscopic Hysterectomy
      Conditions: Fibroma, Bleeding
    • NCT02362009
      Terminated
      South Miami Hospital Fibroid Registry
      Conditions: Uterine Myomas, Leiomyomas, or Fibromas
    • NCT00520078
      Unknown status
      Clinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus Infection
      Conditions: Acrochordon; Skin Tag; Soft Fibroma; Human Papillomavirus; HPV
    • NCT03550703
      Unknown status
      Open Label Immunotherapy of Myoma
      Conditions: Myoma;Uterus; Fibroid Uterus; Leiomyoma; Fibroma
    • NCT01289314
      Unknown status
      Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy
      Conditions: Total Laparoscopic Hysterectomy; Laparoscopic Supracervical Hysterectomy; Fibromas; Abnormal Uterine Bleeding; Dysmenorrhea
    • NCT01801176
      Unknown status
      Peripheral Primitive Fibromatosis
      Conditions: Peripheral Primitive Fibromatosis
    • NCT02406898
      Unknown status
      Evaluation of a Hysteroscopic Morcellator in Hysteroscopic Treatment of Submucosal Fibroids
      Conditions: Evaluate Both Technics on Procedure Duration; Characteristics and Perioperative Complications
    • NCT01998854
      Terminated
      Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation
      Conditions: Menorrhagia; Leiomyoma; Uterine Fibroids; Uterine Fibroma; Uterine Neoplasms
    • NCT04289077
      Active, not recruiting
      Quality of Life of Patients With Desmoid-type Fibromatosis
      Conditions: Desmoid Tumor; Desmoid-type Fibromatosis
    • NCT04281381
      Recruiting
      Observing People With Desmoid-Type Fibromatosis
      Conditions: Desmoid Fibromatosis
    • NCT04195399
      Recruiting
      A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
      Conditions: Desmoid-Type Fibromatosis; Recurrent Desmoid-Type Fibromatosis; Unresectable Desmoid-Type Fibromatosis
    • NCT03627741
      Active, not recruiting
      A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors
      Conditions: Fibromatosis
    • NCT02547831
      Unknown status
      Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
      Conditions: Desmoid-type Fibromatosis
    • NCT02353429
      Unknown status
      Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
      Conditions: Desmoid Type-fibromatosis
    • NCT02066181
      Active, not recruiting
      Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
      Conditions: Desmoid-Type Fibromatosis
    • NCT01265030
      Active, not recruiting
      A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
      Conditions: Desmoid Tumor
    • NCT00978146
      Withdrawn
      Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
      Conditions: Desmoid Tumors; Fibromatosis
    • NCT00287846
      Completed
      Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
      Conditions: Desmoid Tumor
    • NCT00030680
      Completed
      Radiation Therapy in Treating Patients With Aggressive Fibromatoses
      Conditions: Desmoid Tumor
    • NCT03605199
      Recruiting
      Denosumab in Subjects With Giant Cell Rich Tumors of Bone
      Conditions: Aneurysmal Bone Cysts; Giant Cell Granuloma; Osteoblastoma; Chondroblastoma; Chondromyxoid Fibroma
    • NCT02867033
      Active, not recruiting
      National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)
      Conditions: Aggressive Fibromatosis
    • NCT03966742
      Recruiting
      Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
      Conditions: Desmoid; Desmoid Fibromatosis of Skin; Desmoid Neoplasm of Chest Wall; Desmoid Tumor Caused by Somatic Mutation; Aggressive Fibromatoses; Fibromatosis Desmoid; Desmoid Fibromatosis
    • NCT03785964
      Active, not recruiting
      Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
      Conditions: Desmoid Tumor; Aggressive Fibromatosis
    • NCT02495519
      Completed
      A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)
      Conditions: Fibromatosis
    • NCT01981551
      Active, not recruiting
      Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
      Conditions: Desmoid Tumors; Aggressive Fibromatosis
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations